Top Markets
Coin of the day
Nuformix plc Nuformix plc

Nuformix plc

NFX
株式のランク #41013
Nuformix plc, a pharmaceutical company based in the United Kingdom, specializes... Nuformix plc, a pharmaceutical company based in the United Kingdom, specializes in developing therapies for fibrotic diseases and cancer, primarily through the innovative strategy of drug repurposing. Its current development portfolio includes NXP001, which has advanced beyond Phase 1 trials for application in oncology supportive care. Additionally, the company is progressing NXP004, a novel variant of Olaparib, currently in its intellectual property generation stage for oncological indications, and NXP002, which is undergoing pre-clinical evaluation for the treatment of idiopathic pulmonary fibrosis. Nuformix also holds an option agreement with Oxilio Ltd. concerning NXP001 for its oncology applications. Established in 2008, the company maintains its operational base in London.
株価
$0.00185055
時価総額
$48.29K
変化(1日)
-3.55%
変化(1年)
30.31%
GB
取引 Nuformix plc (NFX)

カテゴリー

Nuformix plc(NFX)のP/B比率
September 2026 時点のP/B比率 TTM: 2.01
Nuformix plc の最新の財務報告および株価によると、現在のP/B比率(TTM)は 2.01 です。2024 年末時点でのP/B比率は 0.64 でした。
Nuformix plc の P/B 比率の履歴(2014 ~ 2026)
各年末時点のP/B比率
P/B比率 変化
2026 (TTM) 2.01 -61.14%
2025 5.17 703.62%
2024 0.64 44.29%
2023 0.45 -63.79%
2022 1.23 -46.40%
2021 2.30 -42.90%
2020 4.02 28.15%
2019 3.14 93.67%
2018 1.62 -108.69%
2017 -18.66 -793.31%
2016 2.69 0.00%
2014 0.00 0.00%
同業他社のP/B比率
企業 P/B比率 P/B比率の差
6.5144 224.23%
US
8.5918 327.62%
US
3.9974 98.95%
AU
7.3983 268.22%
NL
- -
CH